Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
Clinical trial NCT01113970 · UNKNOWN
Trial details
- NCT number
- NCT01113970
- Sponsor
- Alaunos Therapeutics
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2013-05-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.